Drug Profile
NE 0080
Alternative Names: NE 1327Latest Information Update: 20 May 2002
Price :
$50
*
At a glance
- Originator Neose Technologies
- Class Antibacterials; Antiulcers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 20 May 2002 Discontinued - Phase-II for Helicobacter infections in Europe (PO)
- 20 May 2002 Discontinued - Phase-II for Helicobacter infections in USA (PO)
- 07 Jul 1999 Phase-II clinical trials for Helicobacter infections in Europe (PO)